Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Norris

Showing results (751-760 of 767) with videos related to

Pageof 77
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
BMC Nephrology|November 22, 2024
The urine protein/creatinine ratio as a reliable indicator of 24-h urine protein excretion across different levels of renal function and proteinuria: the TUNARI prospective studyGabriel Brayan Gutiérrez-Peredo, Iris Montaño-Castellón, Andrea Jimena Gutiérrez-Peredo, et al.
Seminars in Dialysis|April 20, 2017
Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney DiseaseKamyar Kalantar-Zadeh, Susan T Crowley, Srinivasan Beddhu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2018
Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132Jamie L Lahvic, Michelle Ammerman, Pulin Li, et al.
Science Immunology|April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunityTianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
JCI Insight|June 28, 2016
Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertensionFei Liu, Christina Mallarino Haeger, Paul B Dieffenbach, et al.
Science (New York, N.Y.)|November 27, 2001
Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21N Patil, A J Berno, D A Hinds, et al.
Ethnicity & Disease|February 5, 2016
The Healthy Community Neighborhood Initiative: Rationale and DesignArleen F Brown, D'Ann M Morris, Katherine L Kahn, et al.
Molecular Genetics and Metabolism|October 23, 2013
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratioM Mokhtarani, G A Diaz, W Rhead, et al.
Pageof 77

Showing results (751-760 of 767) with videos related to

Sort By:
Pageof 77
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 8, 2000
Intermittent doxercalciferol (1alpha-hydroxyvitamin D(2)) therapy for secondary hyperparathyroidismJ M Frazão, L Elangovan, H M Maung, et al.
BMC Nephrology|November 22, 2024
The urine protein/creatinine ratio as a reliable indicator of 24-h urine protein excretion across different levels of renal function and proteinuria: the TUNARI prospective studyGabriel Brayan Gutiérrez-Peredo, Iris Montaño-Castellón, Andrea Jimena Gutiérrez-Peredo, et al.
Seminars in Dialysis|April 20, 2017
Renal Replacement Therapy and Incremental Hemodialysis for Veterans with Advanced Chronic Kidney DiseaseKamyar Kalantar-Zadeh, Susan T Crowley, Srinivasan Beddhu, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 3, 2001
Efficacy and side effects of intermittent intravenous and oral doxercalciferol (1alpha-hydroxyvitamin D(2)) in dialysis patients with secondary hyperparathyroidism: a sequential comparisonH M Maung, L Elangovan, J M Frazão, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 25, 2018
Specific oxylipins enhance vertebrate hematopoiesis via the receptor GPR132Jamie L Lahvic, Michelle Ammerman, Pulin Li, et al.
Science Immunology|April 26, 2024
Up-regulated PLA2G10 in cancer impairs T cell infiltration to dampen immunityTianxiang Zhang, Weiwei Yu, Xiaoxiao Cheng, et al.
JCI Insight|June 28, 2016
Distal vessel stiffening is an early and pivotal mechanobiological regulator of vascular remodeling and pulmonary hypertensionFei Liu, Christina Mallarino Haeger, Paul B Dieffenbach, et al.
Science (New York, N.Y.)|November 27, 2001
Blocks of limited haplotype diversity revealed by high-resolution scanning of human chromosome 21N Patil, A J Berno, D A Hinds, et al.
Ethnicity & Disease|February 5, 2016
The Healthy Community Neighborhood Initiative: Rationale and DesignArleen F Brown, D'Ann M Morris, Katherine L Kahn, et al.
Molecular Genetics and Metabolism|October 23, 2013
Elevated phenylacetic acid levels do not correlate with adverse events in patients with urea cycle disorders or hepatic encephalopathy and can be predicted based on the plasma PAA to PAGN ratioM Mokhtarani, G A Diaz, W Rhead, et al.
Pageof 77